(Q43436671)

23 November 2017

title

Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial (English)

1 reference

23 November 2017

1 reference

1 reference

Nicola Cherry

1

1 reference

23 November 2017

Kyle Gilmour

2

1 reference

23 November 2017

Philip Hannaford

3

1 reference

23 November 2017

Anthony Heagerty

4

1 reference

23 November 2017

Mohammed Amjed Khan

5

1 reference

23 November 2017

Henry Kitchener

6

1 reference

23 November 2017

Roseanne McNamee

7

1 reference

23 November 2017

Max Elstein

8

1 reference

23 November 2017

Clifford Kay

9

1 reference

23 November 2017

Mourad Seif

10

1 reference

23 November 2017

Hilary Buckley

11

1 reference

23 November 2017

ESPRIT team

12

1 reference

23 November 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

23 November 2017

1 reference

23 November 2017

volume

360

1 reference

23 November 2017

issue

9350

1 reference

23 November 2017

page(s)

2001-2008

1 reference

Hormone replacement therapy, heart disease, and other considerations

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

The protective effects of estrogen on the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

Hemostatic factors according to menopausal status and use of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

Haemostatic changes during continuous oestradiol-progestogen treatment of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

Triglyceride: the forgotten risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

Effect of postmenopausal hormone replacement on atherosclerosis in femoral arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

A clinical trial of estrogen-replacement therapy after ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

Evidence from randomised trials on the long-term effects of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

Risk of recurrent coronary events in relation to use and recent initiation of postmenopausal hormone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

Hormone replacement therapy and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

HRT: an analysis of benefits, risks and costs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912001-0

7 January 2021

10.1016/S0140-6736(02)12001-0

Identifiers

DOI

1 reference

23 November 2017

1 reference